Your browser doesn't support javascript.
loading
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-ß antagonists.
Cirella, Assunta; Bolaños, Elixabet; Luri-Rey, Carlos; Di Trani, Claudia Augusta; Olivera, Irene; Gomis, Gabriel; Glez-Vaz, Javier; Pinci, Beatrice; Garasa, Saray; Sánchez-Gregorio, Sandra; Azpilikueta, Arantza; Eguren-Santamaria, Iñaki; Valencia, Karmele; Palencia, Belén; Alvarez, Maite; Ochoa, Maria C; Teijeira, Álvaro; Berraondo, Pedro; Melero, Ignacio.
Afiliación
  • Cirella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.
  • Bolaños E; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Luri-Rey C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.
  • Di Trani CA; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Olivera I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.
  • Gomis G; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Glez-Vaz J; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.
  • Pinci B; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Garasa S; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.
  • Sánchez-Gregorio S; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Azpilikueta A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.
  • Eguren-Santamaria I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.
  • Valencia K; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Palencia B; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.
  • Alvarez M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.
  • Ochoa MC; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.
  • Teijeira Á; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.
  • Melero I; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
Mol Ther Nucleic Acids ; 33: 668-682, 2023 Sep 12.
Article en En | MEDLINE | ID: mdl-37650116
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Año: 2023 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Año: 2023 Tipo del documento: Article País de afiliación: España